Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3067)
All Articles published online
|
Sep 14, 2006 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gerhardt T, Milz S, Schepke M, Feldmann G, Wolff M, Sauerbruch T, Dumoulin FL. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol 2006; 12(34): 5495-5500 [PMID: 17006987 DOI: 10.3748/wjg.v12.i34.5495] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i34/5495.htm |
| Number | Citing Articles |
| 1 |
Hiromitsu MAEHIRA, Tomoharu SHIMIZU, Eiji MEKATA, Hiromichi SONODA, Tomohiro YAMAGUCHI, Tohru TANI. Evaluation of clinical courses of patients with left obstructive colorectal cancer. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2012; 73(11): 2745 doi: 10.3919/jjsa.73.2745
|
| 2 |
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a review. Biomarkers 2014; 19(6): 437 doi: 10.3109/1354750X.2014.923048
|
| 3 |
Yu-Chen Shiu, Jen-Kou Lin, Chi-Jung Huang, Jeng-Kai Jiang, Ling-Wei Wang, Huei-Chen Huang, Shung-Haur Yang. Is C-Reactive Protein a Prognostic Factor of Colorectal Cancer?. Diseases of the Colon & Rectum 2008; 51(4): 443 doi: 10.1007/s10350-007-9133-z
|
| 4 |
Giulia Malaguarnera, Maria Giordano, Isabella Paladina, Alessandra Rando, Mario Uccello, Francesco Basile, Antonio Biondi, Santo Carnazzo, Innocenza Alessandria, Clorinda Mazzarino. Markers of bile duct tumors. World Journal of Gastrointestinal Oncology 2011; 3(4): 49-59 doi: 10.4251/wjgo.v3.i4.49
|
| 5 |
Bruno C Odisio, Geoffrey W Krampitz, Ravi Murthy, Armeen Mahvash, Milind Javle, Jean-Nicolas Vauthey. Preoperative drainage for perihilar cholangiocarcinoma. The Lancet Gastroenterology & Hepatology 2019; 4(1): 10 doi: 10.1016/S2468-1253(18)30345-5
|
| 6 |
Ana P. Borges, António V. Silva, Paulo Donato. Comparison between Suprapapillary and Transpapillary Uncovered Self-Expandable Metallic Stent Placement for Perihilar Cholangiocarcinoma. Journal of Vascular and Interventional Radiology 2023; 34(8): 1400 doi: 10.1016/j.jvir.2023.03.031
|
| 7 |
Masataka Okuno, Tomoki Ebata, Yukihiro Yokoyama, Tsuyoshi Igami, Gen Sugawara, Takashi Mizuno, Junpei Yamaguchi, Masato Nagino. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma. Journal of Gastroenterology 2016; 51(2): 153 doi: 10.1007/s00535-015-1103-y
|
| 8 |
Ander Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, Alvaro Santos‐Laso, Ainhoa Lapitz, Maria J. Perugorria, Oihane Erice, Esperanza Gonzalez, Raul Jimenez‐Agüero, Adelaida Lacasta, Cesar Ibarra, Alberto Sanchez‐Campos, Juan P. Jimeno, Frank Lammert, Piotr Milkiewicz, Marco Marzioni, Rocio I.R. Macias, Jose J.G. Marin, Tushar Patel, Gregory J. Gores, Ibon Martinez, Félix Elortza, Juan M. Falcon‐Perez, Luis Bujanda, Jesus M. Banales. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2017; 66(4): 1125 doi: 10.1002/hep.29291
|
| 9 |
Christopher D. Briggs, Christopher P. Neal, Christopher D. Mann, William P. Steward, Margaret M. Manson, David P. Berry. Prognostic molecular markers in cholangiocarcinoma: A systematic review. European Journal of Cancer 2009; 45(1): 33 doi: 10.1016/j.ejca.2008.08.024
|
| 10 |
Zi-Ying Lin, Zhen-Xing Liang, Pei-Lin Zhuang, Jie-Wei Chen, Yun Cao, Li-Xu Yan, Jing-Ping Yun, Dan Xie, Mu-Yan Cai. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2827-7
|
| 11 |
Q. Lin, Z.-H. Lin, J. Chen, J.-X. Lin, X. Li, J.-R. Jiang, X.-K. Ma, D.-H. Wu, Z.-H. Chen, M. Dong, L. Wei, T.-T. Wang, D.-Y. Ruan, Z.-X. Lin, J.-Y. Wen, X.-Y. Wu, M.-S. Huang. Prognostic significance of preoperative albumin-to-globulin ratio in patients with cholangiocarcinoma. Current Research in Translational Medicine 2017; 65(2): 83 doi: 10.1016/j.retram.2017.06.002
|
| 12 |
Sven H. Loosen, Mihael Vucur, Christian Trautwein, Christoph Roderburg, Tom Luedde. Circulating Biomarkers for Cholangiocarcinoma. Digestive Diseases 2018; 36(4): 281 doi: 10.1159/000488342
|
| 13 |
Traian Dumitrascu, Dragos Chirita, Mihnea Ionescu, Irinel Popescu. Resection for Hilar Cholangiocarcinoma: Analysis of Prognostic Factors and the Impact of Systemic Inflammation on Long-term Outcome. Journal of Gastrointestinal Surgery 2013; 17(5): 913 doi: 10.1007/s11605-013-2144-2
|
| 14 |
Mitsuru Ishizuka, Hitoshi Nagata, Kazutoshi Takagi, Keiichi Kubota. Influence of Inflammation-Based Prognostic Score on Mortality of Patients Undergoing Chemotherapy for Far Advanced or Recurrent Unresectable Colorectal Cancer. Annals of Surgery 2009; 250(2): 268 doi: 10.1097/SLA.0b013e3181b16e24
|
| 15 |
Dimitra S. Mouliou. C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians. Diseases 2023; 11(4): 132 doi: 10.3390/diseases11040132
|
| 16 |
Mitsuru Ishizuka, Hitoshi Nagata, Kazutoshi Takagi, Toru Horie, Keiichi Kubota. Inflammation-Based Prognostic Score Is a Novel Predictor of Postoperative Outcome in Patients With Colorectal Cancer. Annals of Surgery 2007; 246(6): 1047 doi: 10.1097/SLA.0b013e3181454171
|
| 17 |
Hang Xu, Ping Tan, Jianzhong Ai, Yu Huang, Tianhai Lin, Lu Yang, Qiang Wei. Prognostic Impact of Preoperative Albumin–Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy. Clinical Genitourinary Cancer 2018; 16(5): e1059 doi: 10.1016/j.clgc.2018.06.003
|
| 18 |
Lian-Yuan Tao, Lei Cai, Xiao-Dong He, Wei Liu, Qiang Qu. Comparison of Serum Tumor Markers for Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. The American Surgeon 2010; 76(11): 1210 doi: 10.1177/000313481007601119
|
| 19 |
Basem Azab, Shiksha Kedia, Neeraj Shah, Steven Vonfrolio, William Lu, Ali Naboush, Farhan Mohammed, Scott W. Bloom. The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer. International Journal of Colorectal Disease 2013; 28(12): 1629 doi: 10.1007/s00384-013-1748-z
|
| 20 |
Irinel Popescu, Traian Dumitrascu. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbeck's Archives of Surgery 2014; 399(6): 693 doi: 10.1007/s00423-014-1210-x
|
| 21 |
Sven A. Lang, Jan Bednarsch, Katharina Joechle, Iakovos Amygdalos, Zoltan Czigany, Lara Heij, Tom F. Ulmer, Ulf P. Neumann. Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art. Expert Review of Gastroenterology & Hepatology 2021; 15(5): 497 doi: 10.1080/17474124.2021.1912591
|
| 22 |
Mitsuru Ishizuka, Hitoshi Nagata, Kazutoshi Takagi, Keiichi Kubota. Systemic Inflammatory Response Associated with Distant Metastasis of T1 or T2 Colorectal Cancer. Digestive Diseases and Sciences 2010; 55(11): 3181 doi: 10.1007/s10620-010-1159-8
|
| 23 |
X. Hu, Q. Pang, H. Liu, Z. Qian, H. Jin, L. Zhou, Y. Wang, Z. Man, Z. Li, S. Yang. Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with 125I seeds intracavitary irradiation. Clinical and Translational Oncology 2019; 21(5): 665 doi: 10.1007/s12094-018-1969-2
|
| 24 |
K. Pak, S.-J. Kim, I. J. Kim, D. U. Kim, K. Kim, H. Kim, S. J. Kim. Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma. Nuklearmedizin 2014; 53(02): 26 doi: 10.3413/Nukmed-0566-13-03
|
| 25 |
J K Pine, E Morris, G G Hutchins, N P West, D G Jayne, P Quirke, K R Prasad. Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. British Journal of Cancer 2015; 113(2): 204 doi: 10.1038/bjc.2015.87
|
| 26 |
Bin Wang, Liang Chen, Hao-Teng Chang. Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile. Biomarkers in Medicine 2016; 10(6): 613 doi: 10.2217/bmm-2015-0062
|
| 27 |
Katsuki Miyazaki, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saito, Shinichiro Yamada, Kazunori Tokuda, Shohei Okikawa, Shoko Yamashita, Takeshi Oya, Koichi Tsuneyama, Mitsuo Shimada. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8+ tumor-infiltrating lymphocytes as a predictor of prognosis after resection of intrahepatic cholangiocarcinoma. Surgery Today 2021; 51(12): 1985 doi: 10.1007/s00595-021-02295-5
|
| 28 |
Tushar Patel, Pankaj Singh. Cholangiocarcinoma: emerging approaches to a challenging cancer. Current Opinion in Gastroenterology 2007; 23(3): 317 doi: 10.1097/MOG.0b013e3280495451
|
| 29 |
Mario Fernández-Ruiz, Juan-Manuel Guerra-Vales, Francisco Colina-Ruizdelgado. Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2009; 15(42): 5279-5286 doi: 10.3748/wjg.15.5279
|
| 30 |
Sven H. Loosen, Christoph Roderburg, Katja L. Kauertz, Alexander Koch, Mihael Vucur, Anne T. Schneider, Marcel Binnebösel, Tom F. Ulmer, Georg Lurje, Wenzel Schoening, Frank Tacke, Christian Trautwein, Thomas Longerich, Cornelis H. Dejong, Ulf P. Neumann, Tom Luedde. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17175-7
|
| 31 |
Hiroki Saito, Takehiro Noji, Keisuke Okamura, Takahiro Tsuchikawa, Toshiaki Shichinohe, Satoshi Hirano. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery 2016; 159(3): 842 doi: 10.1016/j.surg.2015.10.027
|
| 32 |
Sven H. Loosen, Christoph Roderburg, Tom Luedde. Reply to: “Is osteopontin a promising prognostic biomarker for cholangiocarcinoma?”. Journal of Hepatology 2018; 68(1): 206 doi: 10.1016/j.jhep.2017.08.027
|
| 33 |
Marcus Wiedmann, Helmut Witzigmann, Joachim Mössner. Clinical Hepatology. 2010; : 1519 doi: 10.1007/978-3-642-04519-6_62
|
| 34 |
Sven H. Loosen, Christoph Roderburg, Katja L. Kauertz, Inês Pombeiro, Catherine Leyh, Fabian Benz, Mihael Vucur, Thomas Longerich, Alexander Koch, Till Braunschweig, Tom F. Ulmer, Christoph Heidenhain, Frank Tacke, Marcel Binnebösel, Maximilian Schmeding, Christian Trautwein, Ulf P. Neumann, Tom Luedde. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma. Journal of Hepatology 2017; 67(4): 749 doi: 10.1016/j.jhep.2017.06.020
|
| 35 |
Wenqin Yue, Bin Liu, Lei Gao, Miaoxia He, Jianmin Wang, Weiping Zhang, Li Chen, Xiaoxia Hu, Lili Xu, Jianmin Yang. The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphoma. Clinica Chimica Acta 2018; 485: 316 doi: 10.1016/j.cca.2018.07.015
|
| 36 |
Campbell SD Roxburgh, Donald C McMillan. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncology 2010; 6(1): 149 doi: 10.2217/fon.09.136
|
| 37 |
Mitsuru Ishizuka, Junji Kita, Mitsugi Shimoda, Kyu Rokkaku, Masato Kato, Tokihiko Sawada, Keiichi Kubota. Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. Journal of Surgical Oncology 2009; 100(1): 38 doi: 10.1002/jso.21294
|
| 38 |
Shinya Okumura, Toshimi Kaido, Yuhei Hamaguchi, Yasuhiro Fujimoto, Atsushi Kobayashi, Taku Iida, Shintaro Yagi, Kojiro Taura, Etsuro Hatano, Shinji Uemoto. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery 2016; 159(3): 821 doi: 10.1016/j.surg.2015.08.047
|
| 39 |
Masataka Okuno, Tomoki Ebata, Yukihiro Yokoyama, Tsuyoshi Igami, Gen Sugawara, Takashi Mizuno, Junpei Yamaguchi, Masato Nagino. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2016; 23(10): 636 doi: 10.1002/jhbp.386
|
| 40 |
Andreas Weber, Claus von Weyhern, Falko Fend, Jochen Schneider, Bruno Neu, Alexander Meining, Hans Weidenbach, Roland M Schmid, Christian Prinz. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World Journal of Gastroenterology 2008; 14(7): 1097-1101 doi: 10.3748/wjg.14.1097
|
| 41 |
Inkeun Park, Jae‐Lyun Lee, Min‐Hee Ryu, Tae‐Won Kim, Sung Sook Lee, Do Hyun Park, Sang Soo Lee, Dong Wan Seo, Sung Koo Lee, Myung‐Hwan Kim. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first‐line palliative chemotherapy. Cancer 2009; 115(18): 4148 doi: 10.1002/cncr.24472
|
| 42 |
Du Hyun Song, In Kuk Cho, Dong Woo Shin, Jong-chan Lee, Jai Young Cho, Yoo-Seok Yoon, Jin-Hyeok Hwang, Ho-Seong Han, Jaihwan Kim. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer. Surgery Today 2021; 51(6): 978 doi: 10.1007/s00595-020-02188-z
|